Vivani Medical (Nasdaq:VANI) subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical ...

Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

About 30 million people around the world have grown legally blind due to retinal diseases. The EPI-RET project has sought for a technical solution for the past twelve years to help these patients.

The firm has announced its readiness to implant a new device, Blindsight, into a human patient. The move comes as part of the company's broader mission to develop brain-computer interfaces (BCIs).

Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...

Neural computation scientists have created a software system that is hoped to improve the function of retinal implants significantly: With the aid of the software, the visual prosthesis "learns" to ...

A retinal prosthesis system can safely, effectively, and reliably restore enough visual function to patients with late-stage retinitis pigmentosa to improve object detection and overall well-being, ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain's visual cortex, has been successfully surgically implanted in the ...

Retinitis pigmentosa and age-related macular degeneration are two significant causes of severe visual dysfunction. In both, the retinal photoreceptors degenerate, preventing successful conversion of ...